查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1812154

亞磷醯胺市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、地區和競爭細分，2020-2030 年

Phosphoramidite Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球亞磷醯胺市場規模為10.4億美元，預計到2030年將達到13.7億美元，複合年成長率為4.86%。亞磷醯胺是關鍵中間體，主要用於寡核苷酸的合成，寡核苷酸在基因治療、分子診斷和個人化醫療中發揮著至關重要的作用。研發投入的不斷增加，加上遺傳疾病和癌症發生率的不斷上升，正在推動對亞磷醯胺的需求。

市場概況
預測期 2026-2030
2024年市場規模 10.4億美元
2030年市場規模 13.7億美元
2025-2030年複合年成長率 4.86%
成長最快的領域 DNA亞磷醯胺
最大的市場 北美洲

市場受益於核酸療法的進步，該療法高度依賴高品質的亞磷醯胺試劑來實現高效且精準的合成。全球亞磷醯胺市場蘊藏著廣闊的機遇，尤其是在寡核苷酸療法和診斷方法日益普及的背景下。持續的技術進步和政府的支持性舉措預計將在預測期內進一步推動市場成長。

關鍵市場促進因素

醫療保健產業的成長

主要市場挑戰

生產成本高

主要市場趨勢

RNA療法的興起

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球亞磷醯胺市場的影響

第5章：全球亞磷醯胺市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型（DNA亞磷醯胺、RNA亞磷醯胺、標記亞磷醯胺、修飾亞磷醯胺、其他）
    • 按應用（藥物研發、診斷開發、其他）
    • 按地區
    • 按公司分類（2024 年）
  • 市場地圖

第6章：北美亞磷醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲亞磷醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太亞磷醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲亞磷醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲亞磷醯胺市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：全球亞磷醯胺市場：SWOT 分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 16 章：競爭格局

  • BOC Sciences
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Glen Research
  • LGC Biosearch Technologies
  • Biosynth Ltd
  • Bioneer Corporation
  • QIAGEN NV
  • PolyOrg, Inc
  • Lumiprobe Corporation

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 30718

Global Phosphoramidite Market was valued at USD 1.04 Billion in 2024 and is expected to reach USD 1.37 Billion by 2030 with a CAGR of 4.86%. Phosphoramidites are crucial intermediates primarily used in the synthesis of oligonucleotides, which play a vital role in gene therapy, molecular diagnostics, and personalized medicine. Rising investments in research and development activities, coupled with the increasing prevalence of genetic disorders and cancer, are fueling demand for phosphoramidites.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.04 Billion
Market Size 2030USD 1.37 Billion
CAGR 2025-20304.86%
Fastest Growing SegmentDNA Phosphoramidites
Largest MarketNorth America

The market benefits from advancements in nucleic acid-based therapeutics, which rely heavily on high-quality phosphoramidite reagents for efficient and precise synthesis. The Global Phosphoramidite Market presents promising opportunities, particularly with the growing adoption of oligonucleotide-based therapies and diagnostics. Continued technological advancements and supportive government initiatives are expected to further propel market growth over the forecast period.

Key Market Drivers

Growth in Healthcare Industry

The rapid expansion of the healthcare industry is a key driver propelling the growth of the global phosphoramidite market. The global healthcare industry generates annual sales exceeding USD 4 trillion. The most significant and profitable segments are pharmaceuticals and biotechnology, accounting for nearly USD 850 billion, and medical technology and diagnostics, exceeding USD 400 billion. Increasing investments in healthcare infrastructure, rising demand for advanced therapeutics, and the growing emphasis on personalized medicine are collectively fueling the need for innovative chemical building blocks such as phosphoramidites.

Phosphoramidites play a critical role in the synthesis of oligonucleotides, which are fundamental components in the development of gene therapies, antisense drugs, and diagnostic tools. Thermo Scientific phosphoramidites are designed to support diverse oligonucleotide synthesis needs, ranging from research applications to manufacturing. For research and early development, the company offers over 136 ready-to-ship phosphoramidites (referred to as amidites) in small pack sizes available through its online catalog. As the healthcare sector continues to evolve with advancements in biotechnology and molecular medicine, the demand for high-quality phosphoramidite reagents is experiencing steady growth.

Key Market Challenges

High Cost of Production

A significant challenge confronting the Global Phosphoramidite Market is the high cost of production, which directly impacts pricing strategies and market competitiveness. The synthesis of phosphoramidites involves complex chemical processes that require high-purity raw materials, sophisticated equipment, and stringent quality control measures to meet the exacting standards demanded by pharmaceutical and biotechnology applications.

These factors collectively contribute to elevated manufacturing expenses, making it difficult for producers to scale operations cost-effectively. Additionally, maintaining compliance with rigorous regulatory requirements further adds to operational costs. The high capital investment in specialized manufacturing facilities and skilled labor also restricts market entry for new players, limiting competitive dynamics.

Key Market Trends

Rise in RNA Therapeutics

The burgeoning field of RNA therapeutics is emerging as a prominent trend shaping the global phosphoramidite market. RNA-based therapies, including mRNA vaccines, siRNA, and antisense oligonucleotides, have gained unprecedented attention due to their potential to address a wide range of diseases with high specificity and efficacy. In the US, there are at least 21 RNA-based therapies approved by the U.S. Food and Drug Administration (FDA) currently available on the market, alongside a robust pipeline of products in clinical development.

RNAi and mRNA-based therapies constitute the largest segments of this pipeline, representing 40% and 37% respectively. Additionally, the broader pipeline includes oligonucleotide, double-stranded RNA (dsRNA), and microRNA (miRNA) products. Phosphoramidites are essential chemical building blocks used in the synthesis of oligonucleotides, making them critical to the production of RNA therapeutics. The rapid advancement and growing adoption of RNA-based drugs in both clinical and commercial settings are driving increased demand for high-purity phosphoramidite reagents.

Key Market Players

  • BOC Sciences
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Glen Research
  • LGC Biosearch Technologies
  • Biosynth Ltd
  • Bioneer Corporation
  • QIAGEN NV
  • PolyOrg, Inc
  • Lumiprobe Corporation

Report Scope

In this report, the Global Phosphoramidite Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Phosphoramidite Market, By Type:

  • DNA Phosphoramidites
  • RNA Phosphoramidites
  • Labeled Phosphoramidites
  • Modifier Phosphoramidites
  • Others

Phosphoramidite Market, By Application:

  • Drug Discovery & Development
  • Diagnostics Development
  • Others

Phosphoramidite Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Phosphoramidite Market.

Available Customizations:

Global Phosphoramidite Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Phosphoramidite Market

5. Global Phosphoramidite Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Others)
    • 5.2.2. By Application (Drug Discovery & Development, Diagnostics Development, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Phosphoramidite Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Phosphoramidite Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Phosphoramidite Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Phosphoramidite Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Phosphoramidite Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Phosphoramidite Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Phosphoramidite Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Phosphoramidite Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Phosphoramidite Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Phosphoramidite Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Phosphoramidite Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Phosphoramidite Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Phosphoramidite Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Phosphoramidite Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Phosphoramidite Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Phosphoramidite Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Phosphoramidite Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Phosphoramidite Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Phosphoramidite Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Phosphoramidite Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Phosphoramidite Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Phosphoramidite Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Phosphoramidite Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Phosphoramidite Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Global Phosphoramidite Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. BOC Sciences
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Thermo Fisher Scientific Inc.
  • 16.3. Merck KGaA
  • 16.4. Glen Research
  • 16.5. LGC Biosearch Technologies
  • 16.6. Biosynth Ltd
  • 16.7. Bioneer Corporation
  • 16.8. QIAGEN NV
  • 16.9. PolyOrg, Inc
  • 16.10. Lumiprobe Corporation

17. Strategic Recommendations

18. About Us & Disclaimer